ArticleJournal of family medicine and primary care2025
COVID-19 vaccine hesitancy in a tribal-state of India: A cross-sectional study.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The delayed acceptance or abject refusal to take vaccines despite the availability of vaccination services has been termed as vaccine hesitancy (VH). The 5C Model of VH includes Confidence, Convenience, Complacency, and Communication as major determinants of VH in the population. Materials and Methods: This study was conducted among vaccinees enrolled at the Vaccination Center of the largest tertiary hospital in the tribal state of Jharkhand. The study was a cross-sectional study aimed to determine the extent of VH for COVID-19 vaccines prevalent in the study population and the associated factors. The study subjects included vaccinees at RIMS, Ranchi Vaccination Center. It included all subjects aged 18 years and above, consenting to be a part of the study. Study participants were recruited from the line list prepared for COVID-19 vaccination from the Co-win portal. A total of 625 participants were recruited. A predesigned, pretested, semistructured questionnaire was administered to all the study participants. Results: Out of the 625 recruited participants, VH was found in 165 subjects. The factor that is the biggest contributor to VH was the fear of the potential long-/short-term side effects of the vaccine (31.7%), which was followed by the fear of the pain from the shot (14.9%) and distrust in the vaccines due to shorter clinical trials (14.9%). Conclusion: V is a significant, living phenomenon that is translating into geographical clustering of epidemics and requires attention on both the micro- and macrolevels to be addressed successfully.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.